SLU-PP-332 20mg

Description

SLU-PP-332 20mg represents the upper research dosing range — a dose that drives comprehensive ERR pathway saturation and the most robust transcriptional shift toward oxidative muscle phenotype and mitochondrial density. At this level, the compound is functioning as a systemic metabolic reprogrammer: fat oxidation capacity is maximised, endurance gene expression is comprehensively upregulated, and the physiological characteristics that separate elite endurance athletes from sedentary individuals are being driven at the cellular level in skeletal muscle, cardiac muscle, and adipose tissue simultaneously. Research at equivalent dose ranges in animal models showed the most dramatic body composition and endurance capacity improvements, alongside favourable metabolic biomarker changes. This is advanced territory — this dose is for researchers and elite performers with established protocols and rigorous monitoring frameworks. Dose precision at this range is especially critical. Every microgram independently verified by Puralytix at 99%+ purity. Comprehensive medical monitoring at this dose is strongly advisable. Baseline and regular metabolic, hepatic, and cardiovascular assessment provides the safety framework required for frontier pharmacology at this dose range.